NDC 51672-1284-01 - Triamcinolone Acetonide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1284
- Requested NDC
- 51672-1284-01
- Package NDCs from labels
- 51672-1284-1, 51672-1284-2, 51672-1284-8, 51672-1284-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-07-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Triamcinolone Acetonide Ointment USP, 0.1% | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-07-03 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamcinolone Acetonide Ointment USP, 0.1% | RPK Pharmaceuticals, Inc. | 2024-12-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamcinolone Acetonide - RedPharm Drug | RedPharm Drug | 2024-07-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamcinolone Acetonide - Proficient Rx LP | Proficient Rx LP | 2024-03-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamcinolone Acetonide Ointment USP, 0.1% | REMEDYREPACK INC. | 2023-08-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamcinolone Acetonide - A-S Medication Solutions | A-S Medication Solutions | 2023-02-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamcinolone Acetonide Ointment USP, 0.1% | NuCare Pharmaceuticals,Inc. | NuCare Pharmceuticals,Inc. | 2022-06-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1284-1 | Triamcinolone Acetonide | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-1284-1 | Triamcinolone Acetonide | 15 g in 1 TUBE | OINTMENT | 15 | 6 | |
| 51672-1284-2 | Triamcinolone Acetonide | 30 g in 1 TUBE | OINTMENT | 30 | 6 | |
| 51672-1284-2 | Triamcinolone Acetonide | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-1284-8 | Triamcinolone Acetonide | 80 g in 1 TUBE | OINTMENT | 80 | 6 | |
| 51672-1284-8 | Triamcinolone Acetonide | 1 in 1 CARTON | OINTMENT | 1 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1284 | TRIAMCINOLONE ACETONIDE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 6 package rows | 20161229_6b4a9a08-f436-4f33-a940-a97c727788f9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-1284-1 | GM - Gram | 51672-1284 | b27f14ad-ee7a-45b1-805a-46429d9604f0 | 1 | 2013-02-13 |
| 51672-1284-2 | GM - Gram | 51672-1284 | a87592bc-7076-4dca-8391-cf772076639a | 1 | 2016-09-02 |
| 51672-1284-8 | GM - Gram | 51672-1284 | f682a100-a1fa-4e62-881b-415731d06fc9 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Triamcinolone Acetonide | ACTIVE INGREDIENT | F446C597KA | TRIAMCINOLONE ACETONIDE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| Triamcinolone Acetonide | ACTIVE MOIETY | F446C597KA | TRIAMCINOLONE ACETONIDE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| medium-chain triglycerides | INACTIVE INGREDIENT | C9H2L21V7U | TRIAMCINOLONE ACETONIDE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | TRIAMCINOLONE ACETONIDE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | TRIAMCINOLONE ACETONIDE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | TRIAMCINOLONE ACETONIDE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nystatin and triamcinolone acetonide | NYSTATIN AND TRIAMCINOLONE ACETONIDE | Macleods Pharmaceuticals Limited | 57c4ebe8-7a8d-4fc0-b6cf-a276b68327fb | 2023-09-07 | Adverse reactions | F446C597KA |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | C9H2L21V7U |
| Lipotox | SQUALENE, CHOLESTERINUM, ESTRADIOL, PROGESTERONE, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, | BioActive Nutritional, Inc. | a1538692-ca00-4e52-9b7e-409767ee27e1 | 2023-09-05 | Warnings | 4T6H12BN9U Z8IX2SC1OH A2I8C7HI9T |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | Z8IX2SC1OH A2I8C7HI9T |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | A2I8C7HI9T |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | Z8IX2SC1OH A2I8C7HI9T |
| Anubis Barcelona Regul OIl | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ARCTIUM MAJUS ROOT EXTRACT | ANUBIS COSMETICS SL | eb905bd0-c600-b8b2-e053-2995a90ad259 | 2023-09-01 | Warnings | Z8IX2SC1OH A2I8C7HI9T |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, GLYCERYL STEARATE SE, HUMULUS LUPULUS (HOPS) CONE EXTRACT | ANUBIS COSMETICS SL | eb7c418b-8bee-26a3-e053-2a95a90a4e96 | 2023-09-01 | Warnings | Z8IX2SC1OH A2I8C7HI9T |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | Macleods Pharmaceuticals Limited | 43481ee3-0419-44c9-93ab-4fab9baa9273 | 2023-08-21 | Adverse reactions | F446C597KA |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | Bryant Ranch Prepack | 70116d71-97a9-4a9b-bf1d-e79c8ef596e2 | 2023-08-04 | Adverse reactions | F446C597KA |
| Barrier Balm | BARRIER BALM | Autumn Harp, Inc. | 01df9746-991b-4363-e063-6294a90aaac6 | 2023-08-01 | Warnings | 4T6H12BN9U |
| Equaline nasal allergy | TRIAMCINOLONE ACETONIDE | United Natural Foods, Inc. dba UNFI | 6efd653e-82ee-43a5-9544-699f2cfabe9d | 2023-08-01 | Warnings | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | A-S Medication Solutions | 0d40e68d-feb5-4061-8b43-515b2f553371 | 2023-07-31 | Adverse reactions | F446C597KA |
| triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | Bryant Ranch Prepack | e4e2aeed-e9c4-4f35-8cd2-7439785d9ffb | 2023-07-17 | Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | A-S Medication Solutions | 9c418bf0-7de3-4389-81e8-b1e2887af7c5 | 2023-07-11 | Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Macleods Pharmaceuticals Limited | 5873c78d-a9d4-49fc-95b8-5d4a368e9109 | 2023-07-01 | Adverse reactions | F446C597KA |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | Macleods Pharmaceuticals Limited | 4dc6fa38-0225-4b99-8cef-4fee72a30f90 | 2023-07-01 | Adverse reactions | 1085636 F446C597KA |
| foster and thrive 24 hour nasal allergy | TRIAMCINOLONE ACETONIDE | Strategic Sourcing Services LLC | eb5e5496-d270-4c26-aac1-0506f458d45b | 2023-06-30 | Warnings | F446C597KA |
| KENALOG-40 | TRIAMCINOLONE ACETONIDE | A-S Medication Solutions | cb0480b8-44ee-4506-b484-dc776c3092dc | 2023-06-15 | Warnings, Adverse reactions | F446C597KA |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | Proficient Rx LP | 7dc12943-7702-4c84-b507-2ea207d02460 | 2023-06-01 | Adverse reactions | F446C597KA |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.